Alkem Laboratories
| Company type | Public |
|---|---|
| BSE: 539523 NSE: ALKEM | |
| Industry | Pharmaceuticals |
| Founded | 1973 |
| Founder | Samprada Singh |
| Headquarters | , India |
Key people |
|
| Products | |
| Revenue | ₹12,964 crore (US$1.5 billion) (2025) |
| ₹2,512 crore (US$300 million) (2025) | |
| ₹2,165 crore (US$260 million) (2025) | |
| Total assets | ₹17,691 crore (US$2.1 billion) (2025) |
| Total equity | ₹12,433 crore (US$1.5 billion) (2025) |
Number of employees | 20,000 (2024) |
| Subsidiaries | Pharmacor Limited, Ascend, Cachet, Enzene, Indchemie, Connect2clinic, Alkem Foundation |
| Website | www |
| Footnotes / references Financials as of 31 March 2025. | |
Alkem Laboratories Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. Specialising in generics and speciality pharmaceuticals, Alkem manufactures and markets pharmaceutical generics, formulations and nutraceuticals across India and global markets.